Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Takeda

www.takeda.com

1-1 Doshomachi 4-chome
Chuo-ku
Osaka
540-8645
Japan

+81 6 6204 2111

Activities

Regulatory | Research & Development | Pharmaceutical

Related Companies

  • Copley Scientific
  • Lonza
  • Icrom SRL
  • Nanoform
  • Merck Life Science KGaA
  • SGS Health Sciences
  • Starlab
  • Edwards Vacuum
  • NSF
  • PCI Pharma Services
  • EECO2
  • Solvias
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Marchesini Group
  • Vectorbuilder Inc
  • Rentschler Biopharma SE
  • Indena

Related Content

Takeda Pharmaceutical to acquire GammaDelta Therapeutics
Takeda Pharmaceutical to acquire GammaDelta Therapeutics
Takeda to evaluate Aptamer Group reagents for drug development
Takeda to evaluate Aptamer Group reagents for drug development
Adaptate Biotherapeutics raises $18 m in Series A2 funding
Adaptate Biotherapeutics raises $18 m in Series A2 funding
Novadiscovery enters clinical simulation collaboration with Takeda
Novadiscovery enters clinical simulation collaboration with Takeda
Future thoughts about pharmaceutical manufacturing
Future thoughts about pharmaceutical manufacturing
Takeda opens cell therapy manufacturing facility in Boston
Takeda opens cell therapy manufacturing facility in Boston
Evox Therapeutics and Takeda sign multitarget rare disease collaboration
Evox Therapeutics and Takeda sign multitarget rare disease collaboration
Charles River secures milestone deals with Takeda and HemaCare
Charles River secures milestone deals with Takeda and HemaCare
Takeda opens first API facility in Ireland
Takeda opens first API facility in Ireland
Takeda opens new drug research facility in California
Takeda opens new drug research facility in California
ISPE names Facility of the Year 2019
ISPE names Facility of the Year 2019
Pharma giants join £9.5 million dementia drug discovery collaboration
Pharma giants join £9.5 million dementia drug discovery collaboration
Only a handful of pharma companies are developing the urgently needed new medicines for the poor
Only a handful of pharma companies are developing the urgently needed new medicines for the poor
New approaches to treat psychiatric disorders
New approaches to treat psychiatric disorders
Takeda shows significant profit dip in Q1
Takeda shows significant profit dip in Q1
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company